Anti-chemokin like receptor 1 humanized antibodies and their therapeutic applications
WO2020165374A1
Bifunctional molecule comprising il-15ra
WO2020127367A1
Humanized anti-human-pd-1 antibody
WO2020127373A1
Bifunctional anti-pd-1/sirpa molecule
WO2020127377A1
Bifunctional anti-pd-1/il-7 molecule
WO2020127369A1
Bifunctional molecule directed against human pd-1
EP3804754A1
Cmklr1 agonists having a resolvin e1-like capability and their therapeutic applications
CA3110139A1
Anti-sirpg compounds
WO2019242900A1
Method of modifying t cell(s) in vitro or ex vivo for improved function in vivo
KR20210006359A
Anti-chemokine-like receptor 1 antibodies and therapeutic uses thereof
AU2019233577A1
Use of anti-human SIRPa v1 antibodies and method for producing anti-SIRPa v1 antibodies
WO2019073080A1
Modified anti-sirpa antibodies and uses thereof
US2020362300A1
Method and preparation for sorting out t effector cells using anti-cd127 antibodies for applications in cell therapy
EP3662081A1
Biomarkers for assessing the response status for treatment of inflammatory condition or disease affecting the digestive tract such as inflammatory bowel disease in human patients
CN110300764A
The new application of anti-SIRPg antibody
EP3573600A1
Method for manufacturing a stable emulsion for peptide delivery
KR20190090005A
Antibodies and polypeptides directed against CD127
US2020384067A1
Improved treatment of cancer
US2019127477A1
NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
